Indeloxazine hydrochloride

This classification denotes an antidepressant agent with the molecular structure C14H17NO2.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 15QZ6NE84E chemically known as morpholine, 2-((1h-inden-7-yloxy)methyl)-, hydrochloride, (+/-)-, but more commonly known as indeloxazine hydrochloride, which bears US NIH Compound Identifier 47517. European Medicines Agency schedules Indeloxazine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02663MIG. Most nations, for tariff and trade purposes, schedule indeloxazine hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, INDELOXAZINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Indeloxazine hydrochloride bears US NLM identifiers UMLS ID C0953067 and NCI Concept Code C81478. SMILES: C1CC2C(C(C1)OCC3CNCCO3)CC=C2.CL.